Pharmaceutical Supply Chain Risk Assessment in the Time of COVID 19/Case Study

2021 ◽  
pp. 697-704
Author(s):  
Jihene Jlassi ◽  
Nesrin Halouani ◽  
Abderrahman El Mhamedi
2021 ◽  
Author(s):  
Abdelrahman Ibrahim Mostafa ◽  
Abdelrahman Mostafa Rashed ◽  
Yasmin Ashraf Alsherif ◽  
Yomna Nagah Enien ◽  
Menatalla Kaoud ◽  
...  

2018 ◽  
Vol 6 (1) ◽  
pp. 21
Author(s):  
Ying Yu Du ◽  
Jun Bin Zhong ◽  
Zi Yue Su ◽  
Xin Peng Yang ◽  
Yi Lan Yao

As an effective way of enterprises financing, supply chain finance has attracted much attention in recent years. However, since supply chain finance has some problems like long financing period, numerous stakeholders and complex effects, banks are at a higher risk carrying out this kind of service. The purpose of this paper is to explore the key factors in supply chain finance risk assessment and study the effective mode of risk elevation. Based on the existing literature and research, this paper uses Z-score to standardize the financial index of 344 medium-sized enterprises in automotive industry chain from October, 2016 to October, 2017 and build a model of supply chain risk assessment and control basing on analytic hierarchy process, principal components analysis and logistic regression analysis. Finally, we summarize how each index affects risk assessment and then analyze the reasons.


Author(s):  
Chad Lin ◽  
Geoffrey Jalleh

The use of Business-to-Business (B2B) e-commerce within the Australian pharmaceutical supply chain can potentially assist in setting up an infrastructure which supports complex, multiparty Internet-based trading and transactions among pharmaceutical manufacturers, wholesalers, hospitals, pharmacies, medical supply importers and exporters, and other players in the healthcare system. Effective use of B2B e-commerce can help these organizations reduce costs in supplying and distributing medicines and other medical-related products to the general public. However, despite high expectations for realizing the benefits of B2B e-commerce in the pharmaceutical supply chain, issues surrounding its evaluation and management remain poorly understood and relatively under-researched. This chapter presents case study findings on key management and evaluation issues and challenges in adopting and utilizing B2B e-commerce systems on eight pharmaceutical organizations in Australia. The key objectives of this study are: (1) to establish current practices and norms in evaluating B2B e-commerce investments and projects in the pharmaceutical industry; and (2) to identify key B2B e-commerce management issues and challenges within the Australian pharmaceutical supply chain. A key contribution of this chapter is the identification and examination of key issues and challenges faced by the pharmaceutical organizations undertaking B2B e-commerce activities within their supply chain. The findings will guide senior executives in these organizations to develop their own approaches or strategies to manage the opportunities and threats that exist in the Australian pharmaceutical supply chain.


2019 ◽  
Vol 1381 ◽  
pp. 012060
Author(s):  
A Nalhadi ◽  
A Kurniasari ◽  
N Djamal ◽  
S Suryani ◽  
S Supriyadi

Sign in / Sign up

Export Citation Format

Share Document